Boston Scientific Corp
NYSE:BSX
Boston Scientific Corp
Other Items
Boston Scientific Corp
Other Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Boston Scientific Corp
NYSE:BSX
|
Other Items
-$1.8B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-1%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Other Items
-$442m
|
CAGR 3-Years
38%
|
CAGR 5-Years
4%
|
CAGR 10-Years
25%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Other Items
-$452.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-30%
|
CAGR 10-Years
-8%
|
|
|
Stryker Corp
NYSE:SYK
|
Other Items
-$4.1B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Abbott Laboratories
NYSE:ABT
|
Other Items
-$251m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-46%
|
CAGR 10-Years
N/A
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Other Items
$1.2B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
Glance View
In the world of medical devices, Boston Scientific Corp. has carved out a significant niche, navigating the intersection of innovation and healthcare with precision. Founded in 1979, the company has built a robust reputation for developing a diverse range of products that address complex medical conditions. Boston Scientific operates through various segments, primarily focusing on interventional medical specialties that target areas such as cardiology, endoscopy, and neuromodulation. Through its relentless pursuit of innovation, the company continues to push boundaries, enhancing the diagnostic and therapeutic capabilities of physicians worldwide. The heartbeat of its operations lies in its extensive research and development endeavors, where cutting-edge technology meets advanced medical knowledge to produce life-enhancing solutions. At its core, Boston Scientific makes money by designing, manufacturing, and selling medical devices used in minimally invasive procedures. Its product portfolio includes solutions for coronary artery disease, heart rhythm disorders, peripheral artery disease, and many other critical ailments. By partnering with healthcare providers, Boston Scientific enables hospitals and clinics to offer high-quality, efficient care that caters to patient needs in a cost-effective manner. Revenue streams flow through direct sales channels and strategic partnerships across global markets, reflecting a combination of organic growth and strategic acquisitions. Moreover, the company actively reinvests in future technologies, ensuring its position as a pioneer in medical advancements while meeting the ever-evolving demands of the industry.
See Also
What is Boston Scientific Corp's Other Items?
Other Items
-1.8B
USD
Based on the financial report for Dec 31, 2025, Boston Scientific Corp's Other Items amounts to -1.8B USD.
What is Boston Scientific Corp's Other Items growth rate?
Other Items CAGR 10Y
-1%
Over the last year, the Other Items growth was 64%. The average annual Other Items growth rates for Boston Scientific Corp have been -7% over the past three years , and -1% over the past ten years .
